NASDAQ:TWST - Twist Bioscience Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $132.00
  • Forecasted Upside: 9.87 %
  • Number of Analysts: 6
  • Breakdown:
  • 1 Sell Ratings
  • 2 Hold Ratings
  • 3 Buy Ratings
  • 0 Strong Buy Ratings
▲ +1.35 (1.14%)

This chart shows the closing price for TWST by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Twist Bioscience Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for TWST and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for TWST

Analyst Price Target is $132.00
▲ +9.87% Upside Potential
This price target is based on 6 analysts offering 12 month price targets for Twist Bioscience in the last 3 months. The average price target is $132.00, with a high forecast of $200.00 and a low forecast of $100.00. The average price target represents a 9.87% upside from the last price of $120.14.

This chart shows the closing price for TWST for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Hold

The current consensus among 6 investment analysts is to hold stock in Twist Bioscience. This rating has held steady since January 2021, when it changed from a Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart

  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 3 buy ratings
  • 1 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 2 buy ratings
  • 1 hold ratings
  • 1 sell ratings
  • 0 strong buy ratings
  • 3 buy ratings
  • 1 hold ratings
  • 1 sell ratings
  • 0 strong buy ratings
  • 3 buy ratings
  • 2 hold ratings
  • 1 sell ratings

Latest Recommendations

  • 0 strong buy ratings
  • 3 buy ratings
  • 2 hold ratings
  • 1 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
6/4/2021The Goldman Sachs GroupInitiated CoverageNeutral$110.00Low
4/12/2021Piper SandlerInitiated CoverageOverweight$150.00Medium
2/5/2021Robert W. BairdBoost Price TargetOutperform$125.00 ➝ $200.00Medium
2/5/2021JPMorgan Chase & Co.DowngradeNeutral ➝ Underweight$100.00High
11/24/2020Robert W. BairdBoost Price TargetOutperform$70.00 ➝ $125.00High
11/24/2020SVB LeerinkBoost Price TargetMarket Perform$90.00 ➝ $100.00High
10/20/2020SVB LeerinkInitiated CoverageMarket PerformHigh
7/8/2020CowenReiterated RatingBuyMedium
2/7/2020Evercore ISIInitiated CoverageBuy$42.00Low
2/3/2020CowenReiterated RatingBuyHigh
5/31/2019Evercore ISIInitiated CoverageOutperform$26.66High
12/2/2018JPMorgan Chase & Co.Initiated CoverageNeutral$27.00 ➝ $25.99High
11/26/2018Robert W. BairdInitiated CoverageOutperformMedium
11/26/2018JPMorgan Chase & Co.Initiated CoverageNeutral ➝ Neutral$27.00Medium
11/26/2018CowenInitiated CoverageOutperformMedium
(Data available from 6/23/2016 forward)
Twist Bioscience logo
Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for drug discovery and development, and DNA as a digital data storage medium. The company has collaboration agreements with ImmunoPrecise Antibodies Ltd.; Victorian Clinical Genetic Services; Vivlion GmbH; and Kyowa Kirin Pharmaceutical Research, Inc. Twist Bioscience Corporation was founded in 2013 and is headquartered in South San Francisco, California.
Read More

Today's Range

Now: $120.14
Low: $118.34
High: $122.00

50 Day Range

MA: $112.66
Low: $88.13
High: $142.06

52 Week Range

Now: $120.14
Low: $40.01
High: $214.07


498,276 shs

Average Volume

861,472 shs

Market Capitalization

$5.87 billion

P/E Ratio


Dividend Yield




Frequently Asked Questions

What sell-side analysts currently cover shares of Twist Bioscience?

The following Wall Street analysts have issued reports on Twist Bioscience in the last year: Cowen Inc, JPMorgan Chase & Co., Piper Sandler, Robert W. Baird, SVB Leerink LLC, The Goldman Sachs Group, Inc., and Zacks Investment Research.
View the latest analyst ratings for TWST.

What is the current price target for Twist Bioscience?

5 Wall Street analysts have set twelve-month price targets for Twist Bioscience in the last year. Their average twelve-month price target is $132.00, suggesting a possible upside of 11.1%. Robert W. Baird has the highest price target set, predicting TWST will reach $200.00 in the next twelve months. JPMorgan Chase & Co. has the lowest price target set, forecasting a price of $100.00 for Twist Bioscience in the next year.
View the latest price targets for TWST.

What is the current consensus analyst rating for Twist Bioscience?

Twist Bioscience currently has 1 sell rating, 2 hold ratings and 3 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in TWST, but not buy more shares or sell existing shares.
View the latest ratings for TWST.

What other companies compete with Twist Bioscience?

How do I contact Twist Bioscience's investor relations team?

Twist Bioscience's physical mailing address is 681 GATEWAY BLVD., SOUTH SAN FRANCISCO CA, 94080. The company's listed phone number is 800-719-0671 and its investor relations email address is [email protected] The official website for Twist Bioscience is